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Nonfilamentous C. albicans Mutants Are Avirulent
Hsiu-Jung Lo,* Julia R. KoÈ hler,*² Beth DiDomenico,³ An alternative approach is based on the assumption
David Loebenberg,³ Anthony Cacciapuoti,³ that the yeast to filament switch is controlled by the
and Gerald R. Fink*§ same morphogenetic pathways in all fungi despite dif-
*Whitehead Institute for Biomedical Research ferences in the inductive signals and the shape and form
and Department of Biology of the filaments. If this assumption is correct, then one
Massachusetts Institute of Technology could identify genes required for morphogenesis in a
Nine Cambridge Center genetically tractable system, clone and knockout the
Cambridge, Massachusetts 02142 homologous genes from Candida, and determine
²Division of Infectious Disease whether these Candida mutants are defective in mor-
Children's Hospital phogenesis and/or pathogenesis. This approach be-
Boston, Massachusetts 02115 came feasible when a filamentous cycle was discovered
³Schering-Plough Research Institute in a laboratory strain of Saccharomyces cerevisiae,
2015 Galloping Hill Road which is amenable to the complete repertoire of modern
K15-4/4700 molecular genetic techniques. Diploid strains of Sac-
Kenilworth, New Jersey 07033 charomyces switch from a unicellular yeast form to a
pseudohyphal form upon starvation for nitrogen (Gi-
meno et al., 1992). This switch depends upon Ste20p,
Summary Ste11p, Ste7p, and Ste12p, elements of a conserved
mitogen-activated protein kinase (MAPK) pathway. Null
Candida albicans and Saccharomyces cerevisiae switch mutations in the genes encoding these proteins are de-
from a yeast to a filamentous form. In Saccharomyces, fective in both mating and filamentous growth (Liu et
this switch is controlled by two regulatory proteins, al., 1993; MoÈ sch et al., 1996).
Ste12p and Phd1p. Single-mutant strains, ste12/ste12 The role of MAPK genes in Candida morphogenesis
or phd1/phd1, are partially defective, whereas the was explored using the information from Saccharo-
ste12/ste12 phd1/phd1 double mutant is completely myces as a guide. To this end, Candida homologs of
defective in filamentous growth and is noninvasive. the STE20, STE7, and STE12 genes were cloned and
The equivalent cph1/cph1 efg1/efg1 double mutant in used to construct null mutations in Candida by transfor-
Candida (Cph1p is the Ste12p homolog and Efg1p is mation-mediated gene replacement. Strains of Candida
the Phd1p homolog) is also defective in filamentous homozygous for mutations in the STE20, STE7, and
growth, unable to form hyphae or pseudohyphae in
STE12 homologs are partially defective in hyphal devel-
response to many stimuli, including serum or macro-
opment on solid media (Liu et al., 1994; KoÈ hler andphages. This Candida cph1/cph1 efg1/efg1 double
Fink, 1996; Leberer et al., 1996). However, these MAPKmutant, locked in the yeast form, is avirulent in a
pathway mutants still form hyphae in liquid culture andmouse model.
in response to serum. One interpretation of this result
(KoÈ hler and Fink, 1996) is that there is a second, Ste12p-Introduction
independent pathway by which serum could induce fila-
ments in Candida.Candida albicans, the most frequently isolated fungal
In this report, we again used Saccharomyces to iden-pathogen in humans (Edwards, 1990), can switch from
tify the Ste12p-independentpathway in Candida. In Sac-a unicellular yeast form into two distinct filamentous
charomyces null Ste2 mutants are only partially defec-forms: pseudohyphae (chains of distinct cells formed
tive for their pseudohyphal development. The geneby the failure of mother and daughter to separate after
responsible for this residual activity is PHD1, whoseeach cell division) and hyphae (long continuous tubes
overexpression was shown previously to enhance pseu-with septae separating each of the nuclei but no distinct
dohyphal growth (Gimeno and Fink, 1994). Double-indentation at the site of septation). This switch is in-
mutant strains that contain deletions of both STE12 andduced by many environmental cues, but perhaps the
PHD1 (e.g., ste12/ste12 phd1/phd1) are completely de-most critical for pathogenicity is the induction by serum
or by macrophages (Shepherd et al., 1980; Dabrowa fective in pseudohyphal growth. Recently, EFG1, the
and Howard, 1981). The ability to switch between these Candida homolog of the Saccharomyces PHD1 gene,
forms is thought to be important for Candida's virulence was cloned. The study of the EFG1 gene showed that
(Cutler, 1991). However, this conjecture has not been a reduced EFG1 expression level suppresses formation
tested by a comparison between wild-type strains and of true hyphae (Stoldt et al., 1997), though pseudohyphal
isogenic mutant strains that are unable to switch. The filaments were still formed in response to serum. We
direct isolation of nonfilamentous mutants is difficult constructed Candida double mutants lacking both
because Candida is diploid and has no known sexual CPH1 and EFG1 function. These Candida cph1/cph1
cycle (Edwards, 1990; Diener and Fink, 1996). efg1/efg1 strains fail to form filaments in response to
serum or other known inducers of filamentous growth
and are avirulent in a mouse infection model.§To whom correspondence should be addressed.
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Figure 1. The Effect of Overexpression of PHD1 on Filamentous and Invasive Growth in ste Mutants of Saccharomyces
Wild-type STE/STE and ste/ste diploids were streaked on synthetic low ammonia dextrose (SLAD) medium, and the resulting colonies were
photographed after 5 days of growth at 308C. The vertical columns I and II were strains transformed with high copy vector without an insert
(vector) and the vertical columns III and IV were strains transformed with a high copy vector containing PHD1 (2 mm PHD1). Columns I and
III were photographed before washing; Columns II and IV were columns I and III, respectively, after washing. (A), STE/STE (L6219, L6220);
(B), phd1/phd1 (L6229, L6230); (C), ste20/ste20 (L6221, L6222); (D), ste11/ste11 (L6231, L6232); (E), ste7/ste7 (L6225, L6226); and (F), ste12/
ste12 (L6227, L6228). Scale bar, 20 mm.
Results the PHD1 gene (phd1/phd1) show only slight diminua-
tion of pseudohyphal growth (Figures 1BI and 1BII). Fur-
thermore, ste12/ste12 mutants have reduced expres-Pseudohyphal Growth in Saccharomyces Is
Controlled by Both a Ste12p-Dependent sion of the filamentous growth reporter FG(Ty)::lacZ
(MoÈ sch et al., 1996), but the phd1/phd1-null mutants doand -Independent Pathway
Pseudohyphal growth in Saccharomyces is controlled not. The b-galactosidase activity of FG(Ty)::lacZ with
respect to PHD1 STE12 (100%) is: STE12 phd1, 100%;by elements of the mating MAPK pathway; however,
previous work had shown that null mutants in that path- PHD1 ste12, 5%; and phd1 ste12, 5%.
To test the hypothesis that PHD1 is responsible forway are only partially defective (Liu et al., 1993; MoÈ sch
et al., 1996). For example, strains homozygous for a the residual pseudohyphal growth of the ste/ste mu-
tants, we constructed a ste12/ste12 phd1/phd1 double-deletion of STE12 (ste12/ste12) and STE7 (ste7/ste7)
form filaments and invade the agar, albeit at a consider- mutant strain. This double mutant forms no visible fila-
ments and fails to invade the agar medium (Figuresably reduced frequency as compared with STE/STE
strains (compare Figures 1AI and 1AII with Figures 1EI, 2D and 2H). Furthermore, this ste12/ste12 phd1/phd1
double mutant does not form long pseudohyphal cells1EII, 1FI, and 1FII). This partial defect suggests that
there are other genes responsible for the residual pseu- in the colony (see Experimental Procedures). Transfor-
mation of the ste12/ste12 phd1/phd1 double mutantdohyphal growth. Since overexpression of the PHD1
gene suppresses the filamentation and invasion defect with either the functional PHD1 or STE12 gene restores
pseudohyphal growth and invasion to the level shownof these ste/ste mutants (Figure 1), we posited that PHD1
function was responsible for the residual activity of by the single-mutant strains (compare Figures 2B, 2F
and 2C, 2G with Figure 1BI, 1BII and 1FI, 1FII). Thethese mutants. Diploid strains containing a deletion of
Nonfilamentous Mutants Are Avirulent
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Figure 2. The ste12/ste12 phd1/phd1 Double
Mutant Is Completely Defective in Pseudohy-
phal Growth
Wild-type and mutant diploids were streaked
on SLAD medium, and the resulting colonies
were photographed after 5 days of growth
at 308C. (A)±(D) were photographed before
washing; (E)±(H) were (A)±(D), respectively,
photographed after washing. (A) and (E) are
STE/STE (L6220); (B) and (F) are ste12/ste12
phd1/phd1 containing a p650 (Kirkman-Cor-
reia et al., 1993) CEN-STE12 plasmid (L6235);
(C) and (G) are ste12/ste12 phd1/phd1 con-
taining an integrated copy of PHD1 (L6236);
(D) and (H) are ste12/ste12 phd1/phd1 (L6234)
containing a vector plasmid. The letters in pa-
rentheses denote a gene introduced into the
strain by transformation. Scale bar, 20 mm.
ste7/ste7 phd1/phd1 double mutant also fails to form EFG1 sequence in the Candida genome, as no other
hybridizing bands are observed by Southern analysisfilaments and is less invasive than either of the single
mutants (data not shown). Thus, both the morphological (Figure 3B). An efg1::hisG-URA3-hisG disruption con-
struct was used to transform a Ura32 Candida strainand reporter analysissuggest that pseudohyphal growth
is controlled by two distinct inputs, a Ste12p-dependent in order to replace the chromosomal EFG1 gene. As
Candida is diploid, there are two copies of the EFG1pathway and a Phd1p-dependent pathway, both of
which can signal pseudohyphal and invasive growth un- gene, which had to be sequentially deleted to construct
the null mutant (see Experimental Procedures). Asder conditions of nitrogen starvation.
shown in Figure 3B, this procedure resulted in Candida
strains lacking an intact copy of the EFG1 gene.Construction of an efg1/efg1 Mutant in Candida
Strains lacking the EFG1 gene are markedly affectedPrevious work had shown that Candida strains con-
in their ability to switch forms on solid medium con-taining null mutations of the CPH1 gene, the Candida
taining serum (Figure 4C). Serum induces efg1/efg1homolog of Saccharomyces STE12 (Liu et al., 1994), are,
strains to form long cells and filaments that are morpho-like theirSaccharomyces counterparts, only partiallyde-
logically different from those found in EFG1/EFG1fective in their ability to switch from the yeast to filamen-
strains. efg1/efg1 strains appear to make many pseu-tous forms. Candida is much more versatile than Sac-
dohyphae, whereas EFG1/EFG1 strains make predomi-charomyces and can switch from the yeast form to
nantly hyphae (compare Figure 4A with Figure 4C). Thepseudohyphae as well as hyphae. This switch occurs
morphological abnormalities of the efg1/efg1 strainson agar plates in response to many external signals.
make it difficult to determine whether there are any trueThe most dramatic switch is observed in response to
hyphae, although the pseudohyphae appear to emanateserum: on plates containingserum and noother nutrient,
from an initial hyphal-like structure. Despite the fact thatCandida yeast form cells switch to form abundant hy-
the efg1/efg1 mutant forms abundant pseudohyphae onphae. The Candida cph1/cph1 strains show reduced
solid agar/serum medium (Figure 4C), this strain fails tohyphal formation on solid media but with time form both
form germ tubes and hyphae in the presence of serumhyphae and pseudohyphae. cph1/cph1 strains respond
(Figures 4C and 5C). Germ tubes are the initial projec-to serum: they form germ tubes when suspended in
tions observed when Candida yeast form cells switchserum and hyphae on solid media containing serum (Liu
to hyphal growth.et al., 1994; KoÈ hler and Fink, 1996; Leberer et al., 1996).
Based on our results with Saccharomyces, we surmised
that serum might induce Candida hyphae via two path- Candida cph1/cph1 efg1/efg1 Mutants Fail to
Switch from Yeast to Filamentous Formsways: a Cph1p- (Ste12p-) dependent pathway and an
Efg1p- (Phd1p-) dependent pathway. Since the efg1/efg1 mutants could still switch from the
yeast form to make a recognizable filament, we madeTo determine whether our results from Saccharo-
myces were relevant to Candida morphogenesis, we cph1/cph1 efg1/efg1 double mutants, which were for-
mally equivalent to the ste12/ste12 phd1/phd1 strainscloned the Candida homolog of the Saccharomyces
PHD1 gene called EFG1 (Stoldt et al., 1997) and con- of Saccharomyces. The cph1/cph1 efg1/efg1 strain was
constructed by transforming a cph1/cph1 ura3/ura3structed disruptions of this EFG1 gene. The predicted
amino acids 188 to 319 of the putative Candida EFG1 Candida strain (see Experimental Procedures). The ge-
notypes of all transformants were verified by Southerngene are 68% identical (81% similar) to residues 170 to
301 of the PHD1 gene. There appears to be only a single analysis (Figure 3B). A comparison of the growth rates
Cell
942
Table 1. Doubling Time
Strain Doubling Timea
(hr)
SC5314 (CPH1/CPH1 EFG1/EFG1) 0.96 6 0.054
HLC37 (CPH1/CPH1 EFG1/efg1) 1.18 6 0.074
HLC52 (CPH1/CPH1 efg1/efg1) 1.15 6 0.074
HLC74 [CPH1/CPH1 efg1/efg1 (EFG1)] 1.11 6 0.131
JKC19 (cph1/cph1 EFG1/EFG1) 1.05 6 0.062
HLC17 (cph1/cph1 EFG1/efg1) 1.05 6 0.087
HLC54 (cph1/cph1 efg1/efg1) 1.03 6 0.100
HLC84 [cph1/cph1 efg1/efg1 (EFG1)] 0.99 6 0.085
aAverage of three independent experiments with standard deviation.
containing serum plates they form colonies of yeast form
cells (Figure 4G) and in liquid serum they remain as
slightly elongated yeast form cells without any visible
indication of germ tube formation (Figure 5G). Further-
more, other treatments that induce CPH1/CPH1 EFG1/
EFG1 strains to form germ tubes and hyphae, such asFigure 3. Disruption of the EFG1 Gene in Candida
high temperature, neutral pH, 2.5 mM N-acetyglucos-(A) The EFG1 open reading frame (solid bar) was replaced by the
amine, 10 mM L-proline plus 2.5 mM glucose, 2.5 mMhisG-URA3-hisG cassette (open bar). The EFG-AB fragment was
used as the probe for Southern blot analysis. The AvaII sites were glutamine plus 2.5 mM glucose (Shepherd et al., 1980;
indicated by arrows. Dabrowa and Howard, 1981; Birse et al., 1993), spider
(B) Southern blots of various strains used in this study. Genomic medium (Liu et al., 1994), and medium 199 (Saporito-
DNA digested with AvaII was from the following strains. Lane 1,
Irwin et al., 1995), fail to induce cph1/cph1 efg1/efg1CPH1/CPH1 EFG1/EFG1 (SC5314); lane 2, CPH1/CPH1 EFG1/efg1
cells, which remain in the yeast form (data not shown).(HLC37); lane 3, cph1/cph1 EFG1/efg1 (HLC17); lane 4, CPH1/CPH1
A functional EFG1 gene was integrated into efg1/efg1efg1/efg1 (HLC52); lane 5, cph1/cph1 efg1/efg1 (HLC54); lane 6,
CPH1/CPH1 EFG1/EFG1 (SC5314); lane 7, CPH1/CPH1 efg1/efg1 strains by transformation. Filamentation was restored
containing an integrated copy of EFG1 (HLC74); lane 8, cph1/cph1 when a functional EFG1 gene was introduced into both
efg1/efg1 containing an integrated copy of EFG1 (HLC84); lane 9, efg1/efg1 and cph1/cph1 efg1/efg1 strains by transfor-
molecular weight standards of which sizes (in kb) are labeled on
mation, showing that the phenotypes of these strainsthe side. (EFG1): a functional EFG1 gene that was introduced into
are a consequence of the efg1 mutation (Figures 4D,the strain by transformation.
4H, 5D, and 5H).
Candida Double Mutants Are Defective in Theirof wild type with all the mutant derivatives in 23 YPD
medium showed that they were all roughly comparable Interaction with Macrophages
To test the interaction of our mutants with host cells, we(Table 1).
The double mutant had a striking phenotype: cph1/ observed the interaction of Candida with a macrophage-
like cell line, IC-21. Approximately 40 to 60 min aftercph1 efg1/efg1 strains fail to form germ tubes and hy-
phae under any conditions we have tested. On agar ingestion by a macrophage, wild-type Candida cells
Figure 4. Filamentous Growth Defect of
cph1/cph1 efg1/efg1 Strains
Cells were grown on 2% agar plus 4% bovine
calf serum medium for 16 hr at 378C. (A)
CPH1/CPH1 EFG1/EFG1 (SC5314); (B) CPH1/
CPH1 EFG1/efg1 (HLC37); (C) CPH1/CPH1
efg1/efg1 (HLC52); (D) CPH1/CPH1 efg1/efg1
containingan integrated copy ofEFG1 (HLC74);
(E) cph1/cph1 EFG1/EFG1 (JKC19); (F) cph1/
cph1 EFG1/efg1 (HLC17); (G) cph1/cph1
efg1/efg1 (HLC54); (H) cph1/cph1 efg1/efg1
containing an integrated copy of EFG1
(HLC84). (EFG1): a functional EFG1 gene that
was introduced into the strain by transforma-
tion. Scale bar, 20 mm.
Nonfilamentous Mutants Are Avirulent
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Figure 5. Germ Tube Formation Defect of
efg1/efg1 and cph1/cph1 efg1/efg1 Strains
Cells were incubated in YPD liquid medium
containing 20% bovine calf serum (Sigma
S-6648) for 2 hr at 378C. (A) CPH1/CPH1
EFG1/EFG1 (SC5314); (B) CPH1/CPH1 EFG1/
efg1 (HLC37); (C) CPH1/CPH1 efg1/efg1
(HLC52); (D) CPH1/CPH1 efg1/efg1 con-
taining an integrated copy of EFG1 (HLC74);
(E) cph1/cph1 EFG1/EFG1 (JKC19); (F) cph1/
cph1 EFG1/efg1 (HLC17); (G) cph1/cph1
efg1/efg1 (HLC54); (H) cph1/cph1 efg1/efg1
containing an integrated copy of EFG1
(HLC84). (EFG1): a functional EFG1 gene that
was introduced into the strain by transforma-
tion. Scale bar, 20 mm.
form germ tubes. Despite vigorous activity of the macro- (1 3 105 cells) kills 50% of the mice 6 days after injection
(Figure 7A). All single-mutant Candida strains are stillphage, the majority of hyphae continue growing, ulti-
virulent, although the virulence patterns do not com-mately piercing the macrophage from within (Figures
pletely parallel the morphology of the strains: the EFG1/6Ac±6Ae). The dynamics vary with the ratio of Candida
efg1 heterozygote, which appears to form hyphae andcells to macrophages. Those hyphae that escape the
pseudohyphae normally, is less virulent than the EFG1/macrophages continue to grow and to produce fresh
EFG1 strain (compare Figure 7A with Figure 7B). Theyeast form cells, which are eventually ingested and in
cph1/cph1 strain has a virulence pattern that is similarturn germinate into hyphae. The culture is transformed
to that of the wild-type strain (Figure 7D), a result thatinto a dense hyphal mat with macrophages impaled on
is consistent with its interaction with macrophages. Thethe hyphae.
efg1/efg1 strain, which is defective in forming germIngestion of the cph1/cph1 Candida mutantby macro-
tubes and hyphae in the presence of serum and in itsphages results in induction of hyphae and destruction
interaction with macrophages, shows reduced viru-of the macrophages (Figures 6Ba±6Bc). The course of
lence: wild type kills half of the mice upon inoculationevents is similar to that when the isogenic CPH1/CPH1
with 105 cells, whereas the efg1/efg1 strain achieves thestrain is ingested. The scenario is quite different with
same level of killing only with an inoculum of 107 cellsthe double mutant. Although the cph1/cph1 efg1/efg1
(compare Figure 7A with Figure 7C). By contrast withstrain is ingested normally by the macrophage, it does
the single mutants, the cph1/cph1 efg1/efg1 double mu-
not form either germ tubes or hyphae once inside. While
tant is nearly avirulent: with inocula of 106 cells or less
ingesting the cph1/cph1 efg1/efg1 Candida cells, the
the double mutant fails to kill in this mouse model. Even
movement and morphology of the macrophage remain
with an inoculum of 1 3 107 cells, half of the mice survive
normal. Macrophages that have internalized as many as after 15 days (Figure 7F).
80 mutant Candida cells remain flat and adhere to the
coverslip even 20 hr after they were infected with Can- Discussion
dida (Figure 6Bh). The efg1/efg1 single-mutant Candida
strain has a distinct phenotype: though most of the Can- Dual Control of Morphogenesis in
dida cells inside macrophages do not form hyphae and Saccharomyces and Candida
their host macrophage retains its morphology (Figures Complete abolition of filamentation in both Saccharo-
6Be and 6Bf), a few ingested cells divide to form fila- myces and Candida requires mutations in two different
ments and rupture the membrane of the macrophage functions: one in a component of the MAPK cascade
(Figure 6Bd). and another in the PHD1/EFG1 gene. Both the Candida
cph1/cph1 efg1/efg1 and the Saccharomyces ste12/
The cph1/cph1 efg1/efg1 Double Mutant Is ste12 phd1/phd1 mutants fail to filament under any con-
Not Virulent in a Mouse dition tested, whereas neither single mutation is suffi-
The virulence of the various mutants was tested in the cient to block this morphogenetic pathway completely.
CF-1 mouse model (see Experimental Procedures). In- One explanation for this dual requirement is that mor-
jection of mice with wild-type Candida is lethal: a high phogenesis is controlled by two parallel signaling path-
inoculum of yeast form cells (1 3 107 cells) kills 90% of ways, each with a different and additive input. For exam-
ple, Ste12p and Phd1p, both likely transcriptionalthe mice 2 days after injection, and even a low inoculum
Cell
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Figure 6. Candida and Macrophage-like Cul-
tured Cell Interaction
(A) (a) Uninfected macrophages inculture me-
dium. Scale bar, 10 mm. (b±e) Wild-type Can-
dida (SC5314). Black arrows point to yeast
form cells; white arrows point to germ tubes.
(b) Macrophage containing Candida that is
forming a germ tube, 1 hr after infection. (c)±
(e) are the same macrophage photographed
at 3, 4, and 6 hr after infection, respectively.
(d) One Candida filament has pierced through
the macrophage's cell membrane; (e) the
macrophage has moved down along the Can-
dida filament, so that the original yeast form
cell is protruding outside the macrophage's
cytoplasm.
(B) Mutant strains of Candida in macro-
phages. (a)±(c) are the same macrophage
photographed at 4, 6, and 9 hr, respectively,
after infection with cph1/cph1 (JKC19). (b)
The hyphae have ruptured the cell membrane
at two points. (c) The macrophage has
rounded up completely andone of the original
yeast form Candida cells is sprouting a sec-
ond germ tube. (d) shows two macrophages
each containing one cell of the efg1/efg1 mu-
tant (HLC52), with a germ tube protruding 3
hr after infection. The macrophages have
rounded up. (e and f) Yeast form efg1/efg1
cells in macrophages 17 hr after infection.
The Candida vacuoles are the white circles
and ovals within the dark fungal cell outline.
The macrophages are flat and adherent to
the coverslip. (g) Yeast form cph1/cph1 efg1/
efg1 cells (HLC54) in macrophages 3 hr after
infection. (h) cph1/cph1 efg1/efg1 in three
macrophages 20 hr after infection, containing
up to 80 yeast cells.
activators, could independently activate a gene(s) re- One interpretation of the differences between the
efg1/efg1 and cph1/cph1 phenotypes is that germ tubequired for filamentation. Although the gene(s) could be
activated by either protein, maximum expression would and hyphal formation are the same developmental
event, one that is distinct from pseudohyphal formation.require the binding of both proteins. The bypass of the
Ste12 defect in filamentation by overexpression of According to this interpretation, efg1/efg1 strains form
pseudohyphae because they are defective in the hyphalPhd1p is consistent with this model. Ste12p has been
shown to bind at a filamentation response element (FRE) pathway and not in the pseudohyphal pathway. Another
interpretation is that pseudohyphal and hyphal forma-(Madhani and Fink, 1997). However, Ste12p and Phd1p
do not act together at the FRE element because expres- tion represent a continuum of stages in a single pathway
of filamentous growth and that a quantitatively strongersion of the FRE:lacZ reporter is reduced only in ste12
and not in phd1 mutants (data not shown). regulatory input is needed to produce hyphae than to
produce pseudohyphae. By contrast, in Saccharo-Of course, the exact nature of the defects of the single
and double mutants must be understood within the con- myces, which does not make hyphae, the ste12/ste12
mutant has a much more dramatic defect in pseudohy-text of the biology of each organism. In Candida, the
efg1/efg1 mutant is more severe than the cph1/cph1 phal formation than that found in the phd1/phd1 mutant.
What is striking is that despite differences in theecology,mutant. The efg1/efg1 mutant appears to make very few
hyphae or germ tubes, yet it still makes pseudohyphae. developmental options, and evolutionary history, the
double mutants in both species are restricted to growthOur results with the efg1/efg1 single mutant are similar
to those reported by another group (Stoldt et al., 1997) in the yeast form.
that recently cloned the same gene. Their results on the
morphology of strains with reduced EFG1 function is The Relationship between Morphogenesis
and Virulence in Candidasimilar to ours: namely, a defect in hyphal formation.
They were unable to obtain the homozygous efg1/efg1 The Candida cph1/cph1 efg1/efg1 mutant shows a dra-
matic reduction in pathogenicity in the mouse. Thisdisruption strain and therefore presumed that EFG1 is
essential for viability. These authors reduced EFG1 ex- strain is remarkably avirulent, even when 107 cells are
injected into the tail vein of a mouse. By contrast, thepression using a repressible promoter construction. Us-
ing a different disruption construct and a different strain, efg1/efg1 and cph1/cph1 single mutants are still viru-
lent, even though the efg1/efg1 mutant shows a patternwe have been able to obtain the efg1/efg1 homozygous
disruptant. that is discernibly different from that of a wild-type
Nonfilamentous Mutants Are Avirulent
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Figure 7. Virulence Assay
CF1 mice were injected with the following
strains: (A), CPH1/CPH1 EFG1/EFG1 (SC5314);
(B), CPH1/CPH1 EFG1/efg1 (HLC37); (C),
CPH1/CPH1 efg1/efg1 (HLC52); (D), cph1/
cph1 EFG1/EFG1 (JKC19); (E), cph1/cph1
EFG1/efg1 (HLC17); (F), cph1/cph1 efg1/efg1
(HLC54). Four concentrations of Candida
were injected into mice: open triangles, 1 3
107; x, 1 3 106; 1, 1 3 105; and closed circles,
1 3 104 cells. In (F), all the mice injected with
1 3 104, 1 3 105, and 1 3 106 cph1/cph1 efg1/
efg1 cells survived.
strain. It is noteworthy that the efg1/efg1 strain is still neoformans, Histoplasma capsulatum, and Blasto-
myces dermatitidis appear to proliferate in the host ex-virulent despite the fact that it is unable to formabundant
clusively as yeast form cells (Bullock, 1990; Chapman,hyphae.
1990; Diamond, 1990). One possibility is that the viru-The interaction between macrophages and the vari-
lence of Candida is due to its ability to switch betweenous Candida strains provides an interesting insight into
growth forms in the host. The filamentous growth formthe functions necessary for virulence. All the strains ap-
may be required to evade the cells of the immune sys-pear to be recognized to an equal degree by the macro-
tem, whereas the yeast form maybe themode of prolifer-phage. However, after being ingested, the wild type is
ation once Candida reaches a target tissue.induced to form a hypha that ultimately kills the macro-
phage. By contrast, the cph1/cph1 efg1/efg1 mutant
Induction of Filamentation in Candidafails to form filaments. In fact, after the macrophage
Our data show that the cph1/cph1 efg1/efg1 mutantingests the cph1/cph1 efg1/efg1 mutant, it continues to
is defective in filament formation under many differentscavenge for more Candida cells and, after 20 hr, can
growth conditions. These varied growth conditions arebe filled with as many as 80 yeast cells. Even when
a broad sample of those known to induce morphogene-engorged with this internal population of yeast, the mac-
sis in Candida (for a review, see Odds, 1985), suggestingrophage appears to retain its adherence, shape, and
that the double mutant may be unable to switch in re-motility.
sponse to any external signal. Knowledge of all theAlthough we have shown that the ability to switch
genes and proteins involved in this dual pathway couldfrom yeast to the filamentous form is required for viru-
reveal important therapeutic targets.lence, our experimental design still leaves open the
question of whether it is the yeast or the hyphal form
Experimental Proceduresthat is responsible for pathogenicity. It is also possible
that genes unrelated to cell shape but regulated by the Strains and Media
transcription factors CPH1 and EFG1 are required for Saccharomyces cerevisiae strains, Candida albicans strains, and
transforming plasmids are listed in Table 2, Table 3, and Table 4,virulence. Other pathogenic fungi such as Cryptococcus
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Table 2. Saccharomyces cerevisiae Strains
Strain Genotype Source
10560-4A MATa his3::hisG leu2::hisG trp1::hisG ura3-52 Fink laboratory collection
10560-6B MATa his3::hisG leu2::hisG trp1::hisG ura3-52 Fink laboratory collection
L6211 MATa his3::hisG leu2::hisG trp1::hisG ura3-52 ste11::URA3 This study
L6212 MATa his3::hisG leu2::hisG trp1::hisG ura3-52 ste11::URA3 This study
L6213 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 phd1::hisG/phd1::hisG This study
L6214 MATa his3::hisG leu2::hisG trp1::hisG ura3-52 ste11::ura3-LEU2-ura3 This study
L6215 MATa his3::hisG leu2::hisG trp1::hisG ura3-52 ste11::ura3-LEU2-ura3 This study
L6216 MATa his3::hisG leu2::hisG trp1::hisG ura3-52 ste11::ura3-LEU2-ura3 (B2068) This study
L6217 MATa his3::hisG leu2::hisG trp1::hisG ura3-52 ste11::ura3-LEU2-ura3 (B2068) This study
L6218 MATa/MATa his3::hisG/his3::hisGleu2::hisG/leu2::hisG trp1::hisG/trp1::hisG ura3-52/ura3-52 This study
ste11::ura3-LEU2-ura3/ste11::ura3-LEU2-ura3
L6219 MATa/MATa his3::hisG/his3::hisG ura3-52/ura3-52 (pCG38, B3161) This study
L6220 MATa/MATa his3::hisG/his3::hisG ura3-52/ura3-52 (pRS202, B3161) This study
L6221 MATa/MATa his3::hisG/his3::hisG ura3-52/ura3-52 trp1::hisG/trp1::hisG ste20::TRP1/ste20::TRP1 This study
(pCG38, B3161)
L6222 MATa/MATa his3::hisG/his3::hisG ura3-52/ura3-52 trp1::hisG/trp1::hisG ste20::TRP1/ste20::TRP1 This study
(pRS202, B3161)
L6223 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG ura3-52/ura3-52 This Study
ste11::ura3-LEU2-ura3/ste11::ura3-LEU2-ura3 (pCG38 B3161)
L6224 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG ura3-52/ura3-52 This study
ste11::ura3-LEU2-ura3/ste11::ura3-LEU2-ura3 (pRS202 B3161)
L6225 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 This study
ste7::LEU2/ste7::LEU2 (pCG38 B3161)
L6226 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 ste7::LEU2/ste7::LEU2 This study
(pRS202 B3161)
L6227 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-62/ura3-52 ste12::LEU2/ste12::LEU2 This study
(pCG38 B3161)
L6228 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 ste12::LEU2/ste12::LEU2 This study
(pRS202 B3161)
L6229 MATa/MATa his3::hisG/his3::hisG ura3-52/ura3-52 phd1::hisG/phd1::hisG (pCG38, B3161) This study
L6230 MATa/MATa his3::hisG/his3::hisG ura3-52/ura3-52 phd1::hisG/phd1::hisG (pRS202, B3161) This study
L6231 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 This study
ste11::ura3-LEU2-ura3/ste11::ura3-LEU2-ura3 (pCG38 B3161)
L6232 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 This study
ste11::ura3-LEU2-ura3/ste11::ura3-LEU2-ura3 (pRS202 B3161)
L6234 MATaMATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 phd1::hisG-URA3-hisG/ This study
phd1::hisG-URA3-hisG ste12::LEU2/ste12::LEU2 (pRS314, pRS316)
L6235 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 phd1::hisG-URA3-hisG/ This study
phd1::hisG-URA3-hisG ste12::LEU2/ste12::LEU2 (pRS314, B2552)
L6236 MATa/MATa his3::hisG/his3::hisG leu2::hisG/leu2::hisG ura3-52/ura3-52 phd1::hisG-URA3-hisG/ This study
phd1::hisG-URA3-hisG ste12::LEU2/ste12::LEU2 (pRS314, HLB6)
All these strains are congenic to the S1278b genetic background.
respectively. Standard media were prepared as described in Sher- Determination of Cell Shape
The shape of cells was analyzed by measuring the dimensions ofman et al. (1986). SLAD medium was prepared as described in
Gimeno et al. (1992); Spider medium was prepared as described in cells growing in colonies after 3 days of growth at 308C on SLAD
medium. Because the ste12/ste12 phd1/phd1 double mutant failsLiu et al. (1994); medium 199 powder was obtained from GIBCO
BRL (31100-084)and used at pH 7 to make 2% agar plates (Saporito- to invade the agar and is completely washed off the plate, we could
not measure the dimension of cells in the agar as described byIrwin et al., 1995). Solid agar/serum medium was 2% agar containing
4% bovine calf serum. Bovine calf serum was obtained from Sigma MoÈsch and Fink (1997). The colonies were removed with a toothpick,
suspended in 15 ml of water, and the cells were analyzed for cell(Sigma S-6648).
shape by light microscopy. Cell shape patterns of different strains
were quantified by determining the length to width (l/w) ratio of 1000Saccharomyces Strains Containing a Disrupted ste11 Gene
cells from six independent colonies. As in our earlier study, cellsSaccharomyces strains, L6211 and L6212 (ste11::URA3) were made
were designated ªlong pseudohyphal cellsº if the ratio length/widthby transforming 10560-4A and 10560-6B strains with a ste11::URA3
was greater than 2.disruption plasmid pNC202 (Rhodes et al., 1990). Plasmid B2387
contains a ura3-LEU2-ura3 cassette that was used to convert URA3
to LEU2 (a gift from Yona Kassir, Technion, Haifa, Israel). L6211 and EFG1 Disruption Construct
The disruption construct was made by first synthesizing short frag-L6212 (ste11::URA3) were transformed with the HindIII fragment of
B2387 containing the ura3-LEU2-ura3 cassette. Leu1 transformants ments from the 59(EFG-AB) and 39(EFG-CD) ends of EFG1 and
inserting the hisG-URA3-hisG in between these fragments. Oligonu-were obtained that had the URA3 gene replaced by the LEU2 gene.
L6214 and L6215 were Leu1, Ura2 transformants from L6211 and cleotides (oligo) EFG-A 59d(gcctcccacattagttgctcag)39 complemen-
tary to the positions 2155 to 2130 nucleotides (nt) (A of the transla-L6212, respectively. To generate a ste11/ste11 diploid, we con-
structed L6216 and L6217 from L6214 and L6215, respectively, by tion initiation codon ATG is designated as 11) of the EFG1 gene
and oligo EFG-B 59d(GAAGATCTgtccttgttgttgatagaacatgtag)39transformation with B2068 containing CEN-STE11-TRP1. L6219 was
constructed by crossing L6216 and L6217 and obtaining segregants complementary to the positions 1213 to 1187 nt in the EFG1 coding
region were used to amplify an EFG-AB fragment. The 39 end of thisof the resulting diploid that lack the CEN-STE11-TRP1 plasmid.
Nonfilamentous Mutants Are Avirulent
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Table 3. Candida albicans Strains
Strain Genotype Sources
SC5314 Wild type (Gillum et al., 1984)
CAI4 ura3::1 imm434/ura3::1 imm434 (Fonzi and Irwin, 1993)
JKC18 ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG (Liu et al., 1994)
JKC19 ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG-URA3-hisG (Liu et al., 1994)
HLC17 ura3::1 imm434/ura3::1 imm434 EFG1/efg1::hisG-URA3-hisG This study
HLC46 ura3::1 imm434/ura3::1 imm434 EFG1/efg1::hisG This study
HLC37 ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG EFG1/efg1::hisG-URA3-hisG This study
HLC44 ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG EFG1/efg1::hisG This study
HLC52 ura3::1 imm434/ura3::1 imm434 efg1::hisG/efg1::hisG-URA3-hisG This study
HLC54 ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG efg1::hisG/efg1::hisG-URA3-hisG This study
HLC67 ura3::1 imm434/ura3::1 imm434 efg1::hisG/efg1::hisG This study
HLC69 ura3::1 imm434/ura3;;1 imm434 cph1::hisG/cph1::hisG efg1::hisG/efg1::hisG This study
HLC74 ura3::1 imm434/ura3::1 imm434 efg1::hisG/efg1::hisG (EFG1) This study
HLC84 ura3::1 imm434/ura3::1 imm434 cph1::hisG/cph1::hisG efg1::hisG/efg1::hisG (EFG1) This study
EFG-AB fragment contains a BglII site within the EFG-B oligo. Oligo were screened for the EFG1/efg1::hisG-URA3-hisG genotype by
PCR using oligo EFG-E 59d(gctgctgtttattgtttgttc)39 complementaryEFG-C 59d(GAAGATCTcattcgtgtacatcaccttctgc) complementary to
the positions 6 to 29 nt after the translation stop codon of the EFG1 to the positions 617 to 600 nt after the translation stop codon of
the EFG1 gene and an oligo 59d(ggcggaaccctgtgatggag)39 comple-gene and oligo EFG-D 59d(gtaccttccgcattagacgcttac)39 comple-
mentary to the positions 570 to 547 nt after the translation stop mentary to the hisG sequence, which is 65 to 46 nt from the junction
of hisG and EFG-CD fragment. HLC37 and HLC17 are CPH1/CPH1codon of the EFG1 gene were used to generate an EFG-CD frag-
ment. The 59 end of this EFG-CD fragment contains a BglII site EFG1/efg1::hisG-URA3-hisG and cph1/cph1 EFG1/efg1::hisG-
URA3-hisG, respectively. To disrupt the second chromosomal copywithin the EFG-C oligo. HLB61 and HLB62 are the pGEM-T vectors
(Promega, CA 3600) containing the EFG-AB and EFG-CD fragment, of EFG1, we derived ura3/ura3 EFG1/efg1 strains by streaking
HLC17 and HLC37 on complete medium containing 5-FOA (whichrespectively. The orientation of each insert was determined by re-
striction mapping. The EFG-AB fragment was inserted in the same selects for recombinants that have lost URA3). The resulting strains
HLC46 and HLC44, CPH1/CPH1 EFG1/efg1::hisG and cph1/cph1direction as lacZ and the EFG-CD was inserted in the opposite
orientation from lacZ. A 0.6 kb BglII-NcoI fragment containing EFG- EFG1/efg1::hisG, respectively, were transformed with the EFG1 dis-
ruption construct. The status of the EFG1 gene, either heterozygousCD fragment from HLB62 was inserted into HLB61 digested with
BglII and NcoI. HLB64 is a plasmid containing both the EFG-AB and or homozygous for the EFG1 deletion allele, was confirmed by
Southern blot analysis.the EFG-CDfragments with a BglII site in between.An approximately
4 kb BglII-BamHI fragment containing the hisG-URA3-hisG cassette
from pUCB-6 (Fonzi and Irwin, 1993) was inserted into HLB64 di- The EFG1 Integrating Plasmid
The wild-type EFG1 gene was used in transformation experimentsgested with BglII to generate HLB67. This EFG1 disruption plasmid
contains EFG-AB-BglII/BglII-hisG-URA3-hisG BamHI/BglII-EFG-CD. to complement the efg1 defect. Restoration of filamentation in the
transformants provided evidence that the phenotypes of the efg1/The EFG-AB-BglII/BglII-hisG-URA3-hisG BamHI/BglII-EFG-CD frag-
ment is released when HLB67 is digested with both SacI and SacII. efg1 strains were a consequence of the efg1 mutation. The full-
length EFG1 gene was identified by hybridizing a 32P-labeled EFG-
AB fragment to colonies of a Candida genomic library (Boone et al.,Deletion of EFG1
Sequential disruption of both alleles of the EFG1 gene was per- 1991). HLB100 identified by this method contains the EFG1 gene in
a Saccharomyces high copy URA3 vector. A 4.2 kb HindIII fragmentformed using the strategy developed by Fonzi and Irwin (1993). The
Candida strains CPH1/CPH1 EFG1/EFG1 (CAI4) (Fonzi and Irwin, with the EFG1 gene from HLB100 was inserted into pRC2312, a
vector containing Candida LEU2 and URA3 genes (Cannon et al.,1993) and cph1/cph1 EFG1/EFG1 (JKC18) (Liu et al., 1994) were
transformed with the EFG1 disruption construct. Transformants 1992), at the HindIII site to create plasmid HLB134. HLB134 digested
Table 4. Plasmids
Plasmid Description Sources
B2068 STE11 TRP1 CEN plasmid Fink laboratory collection
B2387 ura3-LEU2-ura3 cassette Yona Kassir
B3161 pFG(TYA)::lacZ-HIS3 plasmid (Mosch et al., 1996)
HLB6 3.1 kb SacI-BamH1 fragment containing EFG1 in pRS306 This study
HLB61 EFG-AB fragment in pGEM-T vector This study
HLB62 EFG-CD fragment in pGEM-T vector This study
HLB64 EFG-ABCD fragment in pGEM-T vector This study
HLB67 EFG-AB-BglII/BglII-hisG-URA3-hisG BamHI/BglII-EFG-CD This study
HLB100 EFG1 URA3 2 mm plasmid This study
HLB134 4.2 kb HindIII fragment with EFG1 in pRC2312 This study
p650 STE12 CEN plasmid (Kirkman-Correia et al., 1993)
pCG38 PHD1 URA3 2 mm plasmid (Gimeno and Fink, 1994)
pNC202 ste11::URA3 disruption plasmid (Rhodes et al., 1990)
pRC2312 LEU2 URA3 ARS C. albicans plasmid (Cannon et al., 1992)
pRS202 URA3 2 mm plasmid (Gimeno and Fink, 1994)
pRS306 URA3 integrating plasmid (Sikorski and Hieter, 1989)
pRS314 TRP1 CEN plasmid (Sikorski and Hieter, 1989)
pRS316 URA3 CEN plasmid (Sikorski and Hieter, 1989)
pUCB-6 hisG-URA3-hisG cassette for C. albicans (Fonzi and Irwin, 1993)
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with BstEII within the LEU2 gene was used to integrate linearized Schering-Plough Research Institute. J. R. K. was supported by Na-
tional Research Service Award F32A109236. G. R. F. is an AmericanHLB134 into the LEU2 locus in Candida.
Cancer Society Professor of Genetics.
Growth Rate
The doubling times of Candida strains were determined in 23 YPD Received June 13, 1997; revised July 28, 1997.
at 378C, which is close to the human body temperature. Candida
strains grown in 23 YPD at 378C remain in the yeast form. An over- References
night culture in 23 YPD at 378C was diluted 1 to 500 into fresh
medium, grown at 378C, and the density (OD600) of each culture was Birse, C.E., Irwin, M.Y., Fonzi, W.A., and Sypherd, P.S. (1993). Clon-
determined every hour. The doubling times shown in Table 1 are
ing and characterization of ECE1, a gene expressed in association
the average of three independent experiments.
with cell elongation of the dimorphic pathogen Candida albicans.
Infect. Immun. 61, 3648±3655.
Interaction of Candida and Macrophages
Boone, C., Sdicu, A., Laroche, M., and Bussey, H. (1991). IsolationThe interaction between Candida and the macrophages was studied
from Candida albicans of a functional homolog of the Saccharo-using the cell line IC-21 (ATCC TIB-186) derived from normal mouse
myces cerevisiae KRE1 gene, which is involved in cell wall beta-peritoneal macrophages, transformed with SV40. The cells were
glucan synthesis. J. Bacteriol. 173, 6859±6864.maintained in RPMI1640 (GIBCO BRL) with 10% fetal bovine serum
Bullock, W.E. (1990). Histoplasma capsulatum. In Principles and(GIBCO BRL), 100 U/ml penicillin, and 100 mg/ml streptomycin at
Practice of Infectious Diseases, G.L. Mandell, R.G. Douglas, and378C in 5% CO2. For microscopy, cells were grown on 25 mm diame-
J.E. Bennett, eds. (New York: Churchill Livingstone), pp. 2340±2353.ter coverslips, No. 1 thickness, which were placed into a 378C heated
microscopy chamber and covered with ca. 6 ml medium and silicon Cacciapuoti, A., Loebenberg, D., Parmegiani, R., Antonacci, B., Nor-
oil. Macrophages retain their adherence to the coverslip, their flat ris, C., Moss, E.L., Menzel, F., Yarosh-Tomaine, T., Hare, R.S., and
spread out shape, and their motility for at least 20 hr under these Miller, G.H. (1992). Comparison of SCH 39304, fluconazole, and
conditions. ketoconazole for treatment of systemic infections in mice. Antimi-
For these interaction experiments, Candida was grown to satura- crob. Agents Chemo. 36, 64±67.
tion in YPD (4% glucose) at 378C. Greater than 95% of cells were Cannon, R.D., Jenkinson, H.F., and Shepherd, M.G. (1992). Cloning
in the yeast form. Before mixing the yeast with macrophages, the and expression of Candida albicans ADE2 and proteinase genes on
yeast cells were washed twice with PBS and counted with a hemocy- a replicative plasmid in Candida and in Saccharomyces cerevisiae.
tometer. Candida were added to macrophages in a microscope Mol. Gen. Genet. 235, 453±457.
chamber during time lapse microscopy or in the cell culture dish
Chapman, S.W. (1990). Blastomyces dermatitidis. In Principles and
using RPMI 1640 medium without serum, with five washes to remove
Practice of Infectious Diseases, G.L. Mandell, R.G. Douglas, andextracellular Candida 1 hr after infection and subsequent placement
J.E. Bennett, eds. (New York: Churchill Livingstone), pp. 2353±2365.of the coverslip into the microscope chamber.
Cutler, J.E. (1991). Putative virulence factors of Candida albicans.Phase contrast time lapse videomicroscopy was performed on a
Annu. Rev. Microbiol. 45, 187±218.Nikon Diaphot 300 inverted microscope equipped with a 403 Fluor
Dabrowa, N., and Howard, D.H. (1981). Proline uptake in Candidaobjective and 23 relay lens. Video frames were acquired with a
albicans. J. Gen. Microbiol. 127, 391±397.Hamamatsu Newvicon C2400-07 camera, digitized, averaged (eight
frames), and eventually stored on CD-ROM. Both image acquisition Diamond, R.D. (1990). Cryptococcus neoformans. In Principles and
and subsequent analysis were performed on a Pentium PC com- Practice of Infectious Diseases, G.L. Mandell, R.G. Douglas, and
puter with Metamorph imaging software (Universal Imaging Corpo- J.E. Bennett, eds. (New York: Churchill Livingstone), pp. 2331±2340.
ration, West Chester, PA). Light exposure was kept to a minimum Diener, A.C., and Fink, G.R. (1996). DLH1 is a functional Candida
by shuttering the light source. albicans homologue of the meiosis-specific gene DMC1. Genetics
143, 769±776.
The Mouse Model for Candida Virulence
Edwards, E.J.J. (1990). Candida species. In Principles and PracticeCF1 mice (white, male) from Charles River Laboratories (Wilmington,
of Infectious Diseases,G.L. Mandell, R.G. Douglas, and J.E. Bennett,MA) weighing between 18 and 20 g were used to test the virulence
eds. (New York: Churchill Livingstone), pp. 1943±1958.of different strains. An experiment was initiated by growing the
Fonzi, W.A., and Irwin, M.Y. (1993). Isogenic strain construction andCandida strains on YPD plates for 48 hr at 288C, suspending the
gene mapping in Candida albicans. Genetics 134, 717±728.cells in saline, and adjusting them to the desired concentration after
Gimeno, C.J., and Fink, G.R. (1994). Induction of pseudohyphalmeasurement of OD (Cacciapuoti et al., 1992). The actual concentra-
growth by overexpression of PHD1, a Saccharomyces cerevisiaetion was then verified by counting the cells in a hemocytometer and
gene related to transcriptional regulators of fungal development.by plating to determine the viable count. Each Candida strain was
Mol. Cell. Biol. 14, 2100±2112.tested for virulence by injecting 0.1 ml of cells into the tail vein of
a mouse. Ten mice were injected for each Candida strain at each Gimeno, C.J., Ljungdahl, P.O., Styles, C.A., and Fink, G.R. (1992).
concentration of cells. Survival was monitored daily. These studies Unipolar cell divisions in the yeast Saccharomyces lead to filamen-
were carried out in accordance with the NIH Guide to the Care tous growth: regulation by starvation and RAS. Cell 68, 1077±1090.
and Use of Laboratory Animals and the Animal Welfare Act in an Kirkman-Correia, C., Stroke, I.L., and Fields, S. (1993). Functional
AAALAC-accredited program. domains of the yeast STE12 protein, a pheromone-responsive tran-
scriptional activator. Mol. Cell. Biol. 13, 3765±3772
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